Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 65 articles:
HTML format
Text format



Single Articles


    February 2019
  1. SKIPPER N, Gaulke A, Sildorf SM, Eriksen TM, et al
    Association of Type 1 Diabetes With Standardized Test Scores of Danish Schoolchildren.
    JAMA. 2019;321:484-492.
    PubMed     Text format     Abstract available


    January 2019
  2. LUO J, Khan NF, Manetti T, Rose J, et al
    Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
    JAMA. 2019;321:374-384.
    PubMed     Text format     Abstract available


  3. LIPSKA KJ
    Insulin Analogues for Type 2 Diabetes.
    JAMA. 2019;321:350-351.
    PubMed     Text format    


  4. SIMHA V, Shah P
    Perioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery.
    JAMA. 2019 Jan 7. pii: 2720429. doi: 10.1001/jama.2018.20922.
    PubMed     Text format    


  5. GRENNAN D
    Diabetic Foot Ulcers.
    JAMA. 2019;321:114.
    PubMed     Text format    


    December 2018
  6. LOTTA LA, Wittemans LBL, Zuber V, Stewart ID, et al
    Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
    JAMA. 2018;320:2553-2563.
    PubMed     Text format     Abstract available


  7. SLOMSKI A
    Dual Receptor Agonist for Type 2 Diabetes.
    JAMA. 2018;320:2521.
    PubMed     Text format    


    November 2018
  8. TUNG EL, Davis AM, Laiteerapong N
    Guidelines on Glycemic Targets for Persons With Type 2 Diabetes-Reply.
    JAMA. 2018;320:1937-1938.
    PubMed     Text format    


  9. KANSAGARA D, Qaseem A, Wilt TJ
    Guidelines on Glycemic Targets for Persons With Type 2 Diabetes.
    JAMA. 2018;320:1937.
    PubMed     Text format    


  10. ROSENSTOCK J, Perkovic V, Johansen OE, Cooper ME, et al
    Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
    JAMA. 2018 Nov 9. pii: 2714646. doi: 10.1001/jama.2018.18269.
    PubMed     Text format     Abstract available


    October 2018
  11. ABBASI J
    To Prevent Cardiovascular Disease, Pay Attention to Pregnancy Complications.
    JAMA. 2018 Oct 17. pii: 2708197. doi: 10.1001/jama.2018.14645.
    PubMed     Text format    


  12. FISHER DP, Johnson E, Haneuse S, Arterburn D, et al
    Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
    JAMA. 2018;320:1570-1582.
    PubMed     Text format     Abstract available


  13. KING WC, Hinerman AS, Belle SH, Wahed AS, et al
    Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes.
    JAMA. 2018;320:1560-1569.
    PubMed     Text format     Abstract available


  14. SENAT MV, Affres H, Bouyer J
    Glyburide vs Insulin for Gestational Diabetes-Reply.
    JAMA. 2018;320:1384.
    PubMed     Text format    


  15. PENG S, Li C, Sun X
    Glyburide vs Insulin for Gestational Diabetes.
    JAMA. 2018;320:1383-1384.
    PubMed     Text format    


  16. OSPINA NS, Young WF Jr, Ghayee HK
    Diagnostic Testing for Elevated Cortisol in the Setting of an Adrenal Mass.
    JAMA. 2018;320:1373-1374.
    PubMed     Text format    


    September 2018
  17. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;320:1163-1171.
    PubMed     Text format     Abstract available


  18. LEBLANC ES, Patnode CD, Webber EM, Redmond N, et al
    Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;320:1172-1191.
    PubMed     Text format     Abstract available


  19. JIN J
    Behavioral Interventions for Weight Loss.
    JAMA. 2018;320:1210.
    PubMed     Text format    


  20. LOWE WL JR, Scholtens DM, Lowe LP, Kuang A, et al
    Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity.
    JAMA. 2018;320:1005-1016.
    PubMed     Text format     Abstract available


    August 2018
  21. ABBASI J
    Oral GLP-1 Analog for Type 2 Diabetes on the Horizon.
    JAMA. 2018;320:539.
    PubMed     Text format    


    June 2018
  22. RUBIN R
    Phone Apps for Patients With Diabetes.
    JAMA. 2018;319:2469.
    PubMed     Text format    


  23. XIANG AH, Wang X, Martinez MP, Page K, et al
    Maternal Type 1 Diabetes and Risk of Autism in Offspring.
    JAMA. 2018 Jun 23. pii: 2685775. doi: 10.1001/jama.2018.7614.
    PubMed     Text format    


  24. LIPSKA KJ, Parker MM, Moffet HH, Huang ES, et al
    Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
    JAMA. 2018 Jun 23. pii: 2685850. doi: 10.1001/jama.2018.7993.
    PubMed     Text format     Abstract available


  25. CROWLEY MJ, Maciejewski ML
    Revisiting NPH Insulin for Type 2 Diabetes: Is a Step Back the Path Forward?
    JAMA. 2018 Jun 23. pii: 2685849. doi: 10.1001/jama.2018.8033.
    PubMed     Text format    



  26. Ertugliflozin for Type 2 Diabetes.
    JAMA. 2018;319:2434-2435.
    PubMed     Text format    


  27. TUNG EL, Davis AM, Laiteerapong N
    Glycemic Control in Nonpregnant Adults With Type 2 Diabetes.
    JAMA. 2018;319:2430-2431.
    PubMed     Text format    


    May 2018
  28. ABBASI J
    For Patients With Type 2 Diabetes, What's the Best Target Hemoglobin A1C?
    JAMA. 2018 May 30. pii: 2683543. doi: 10.1001/jama.2018.5420.
    PubMed     Text format    


  29. HEWITT DB, Barnard C, Bilimoria KY
    Improving Emergency Insulin Administration-Reply.
    JAMA. 2018;319:1937-1938.
    PubMed     Text format    


  30. SENAT MV, Affres H, Letourneau A, Coustols-Valat M, et al
    Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2018;319:1773-1780.
    PubMed     Text format     Abstract available


  31. COUSTAN DR, Barbour L
    Insulin vs Glyburide for Gestational Diabetes.
    JAMA. 2018;319:1769-1770.
    PubMed     Text format    


    April 2018
  32. ZHENG SL, Roddick AJ, Aghar-Jaffar R, Shun-Shin MJ, et al
    Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.
    JAMA. 2018;319:1580-1591.
    PubMed     Text format     Abstract available


  33. SHAPIRO AR
    Continuous Glucose Monitors for Insulin Dosing-Reply.
    JAMA. 2018;319:1384.
    PubMed     Text format    


  34. BECK RW
    Continuous Glucose Monitors for Insulin Dosing.
    JAMA. 2018;319:1383.
    PubMed     Text format    


    March 2018
  35. COGSWELL ME, Loria CM, Terry AL, Zhao L, et al
    Estimated 24-Hour Urinary Sodium and Potassium Excretion in US Adults.
    JAMA. 2018;319:1209-1220.
    PubMed     Text format     Abstract available


  36. DE BOER IH, Bakris G, Cannon CP
    Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations.
    JAMA. 2018 Mar 15. pii: 2675563. doi: 10.1001/jama.2018.0642.
    PubMed     Text format    


    February 2018
  37. MOORE A, Derry S, Wiffen P
    Gabapentin for Chronic Neuropathic Pain.
    JAMA. 2018;319:818-819.
    PubMed     Text format     Abstract available


  38. VOELKER R
    Diabetic Foot Ulcers Heal With Shock Wave Therapy.
    JAMA. 2018;319:649.
    PubMed     Text format    


  39. SCHILLINGER D, Huey N
    Messengers of Truth and Health-Young Artists of Color Raise Their Voices to Prevent Diabetes.
    JAMA. 2018 Feb 14. pii: 2672777. doi: 10.1001/jama.2018.0986.
    PubMed     Text format    


  40. KARGES B, Binder E, Rosenbauer J
    Complications With Insulin Pump Therapy vs Insulin Injection Therapy-Reply.
    JAMA. 2018;319:503-504.
    PubMed     Text format    


    January 2018
  41. IKRAMUDDIN S, Korner J, Lee WJ, Thomas AJ, et al
    Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    JAMA. 2018;319:266-278.
    PubMed     Text format     Abstract available


  42. ABBASI J
    Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes.
    JAMA. 2018;319:215-217.
    PubMed     Text format    


  43. JAKOBSEN GS, Smastuen MC, Sandbu R, Nordstrand N, et al
    Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities.
    JAMA. 2018;319:291-301.
    PubMed     Text format     Abstract available


  44. SALMINEN P, Helmio M, Ovaska J, Juuti A, et al
    Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    JAMA. 2018;319:241-254.
    PubMed     Text format     Abstract available


  45. SHUBECK S, Dimick JB, Telem DA
    Long-term Outcomes Following Bariatric Surgery.
    JAMA. 2018;319:302-303.
    PubMed     Text format    


  46. KNIP M, Akerblom HK, Al Taji E, Becker D, et al
    Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
    JAMA. 2018;319:38-48.
    PubMed     Text format     Abstract available


  47. HAMPTON T
    Smart Artificial Beta Cells May Help Treat Diabetes.
    JAMA. 2018;319:11-12.
    PubMed     Text format    


    December 2017
  48. BANCKS MP, Kershaw K, Carson AP, Gordon-Larsen P, et al
    Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle Adulthood.
    JAMA. 2017;318:2457-2465.
    PubMed     Text format     Abstract available


  49. RIED-LARSEN M, Johansen MY, Pedersen BK
    Intensive Lifestyle Intervention for Type 2 Diabetes-Reply.
    JAMA. 2017;318:2494-2495.
    PubMed     Text format    


  50. GIUGLIANO D, Maiorino MI, Esposito K
    Intensive Lifestyle Intervention for Type 2 Diabetes.
    JAMA. 2017;318:2494.
    PubMed     Text format    


  51. TING DSW, Cheung CY, Lim G, Tan GSW, et al
    Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.
    JAMA. 2017;318:2211-2223.
    PubMed     Text format     Abstract available


    November 2017
  52. SLOMSKI A
    Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  53. SLOMSKI A
    Continuous Glucose Monitoring in Pregnant Women With Diabetes.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  54. KRISCHER JP, Schatz DA, Bundy B, Skyler JS, et al
    Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1891-1902.
    PubMed     Text format     Abstract available


  55. LANE W, Bailey TS, Gerety G
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply.
    JAMA. 2017;318:1828-1829.
    PubMed     Text format    


  56. ZULEWSKI H, Keller U
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes.
    JAMA. 2017;318:1828.
    PubMed     Text format    


  57. SHAHRAZ S, Pittas AG, Saadati M, Thomas CP, et al
    Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014.
    JAMA. 2017;318:1825-1827.
    PubMed     Text format    


    October 2017
  58. SLOMSKI A
    Liraglutide May Reduce Diabetic Kidney Disease.
    JAMA. 2017;318:1532.
    PubMed     Text format    


  59. GAO P, Tang X, Hu Y
    Prediabetes Prevalence in China-Reply.
    JAMA. 2017;318:1612-1613.
    PubMed     Text format    


  60. FU N, Jiang Y, Sun W
    Prediabetes Prevalence in China.
    JAMA. 2017;318:1611-1612.
    PubMed     Text format    


  61. DAVIES M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, et al
    Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1460-1470.
    PubMed     Text format     Abstract available


  62. VOS RC, Rutten GEHM
    Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
    JAMA. 2017;318:1489-1490.
    PubMed     Text format     Abstract available


  63. KARGES B, Schwandt A, Heidtmann B, Kordonouri O, et al
    Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    JAMA. 2017;318:1358-1366.
    PubMed     Text format     Abstract available


  64. HART T, Milner R, Cifu A
    Management of a Diabetic Foot.
    JAMA. 2017;318:1387-1388.
    PubMed     Text format    


    August 2017
  65. KUEHN BM
    Pilot Programs Seek to Integrate Genomic Data Into Practice.
    JAMA. 2017;318:410-412.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: